
Leo Cancer Care
Stand-up CT scanner and radiotherapy system that reduces the cost of radiotherapy and improves cancer patient outcomes.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor investor investor investor investor | €0.0 | round | |
* | N/A | Series C | |
Total Funding | 000k |
Related Content
Leo Cancer Care is a medical technology company focused on developing and commercializing a new approach to radiation therapy. The company has developed a range of solutions for both photon and particle therapy that utilize an upright patient positioning system. This method challenges the conventional lie-down treatment approach, aiming to improve patient comfort and treatment accuracy.
The company's product portfolio includes the 'Marie' system, a particle therapy solution that integrates an upright patient positioning platform with a fan beam CT scanner. This system is designed to be 'beam agnostic', allowing for integration with existing fixed-beam radiation therapy technologies. By avoiding the need for large, rotating gantries, the company's solutions can offer significant cost savings to healthcare providers, potentially expanding access to advanced cancer care.
Leo Cancer Care operates in the global oncology market, with a focus on providing more effective and efficient radiotherapy options. The company is actively seeking regulatory clearance for its products, including a pending 510(k) decision from the FDA for its 'Marie' solution, which would allow for its commercialization in the United States.
Keywords: radiotherapy, oncology, particle therapy, photon therapy, medical devices, cancer treatment, upright positioning, patient care, healthcare technology, cost reduction